Ozempic Just Showed Up in Rheumatology. You prescribe it…

Ozempic Just Showed Up in Rheumatology. You prescribe it for diabetes. Cardiologists use it for heart disease. Oncologists are watching it for cancer. Now a massive real world study just added autoimmune disease to the list. 484,467 patients with autoimmune disease and obesity. 10 years of data. Published in Journal of the American Heart Association. The finding: GLP-1 drugs like semaglutide were associated with dramatically lower risks in patients with autoimmune conditions, a population already carrying 40 to 100% higher cardiovascular and clot risk than the general population. The numbers are hard to ignore: GLP-1RA users showed 31% lower risk of pulmonary embolism, 17% lower risk of venous thromboembolism, 21% lower risk of stroke o